Drawing for INVIBIO BIOMATERIAL SOLUTIONS

USPTO serial 79389638

INVIBIO BIOMATERIAL SOLUTIONS

Reviewed by CopyMark Law Group

Reg. 7691404Status 700Registered
Filing date
Status date
Registration date
Feb 18, 2025
Examiner
MANCA, ALBERTO I
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with INVIBIO BIOMATERIAL SOLUTIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David W. Staple

David W. Staple Casimir Jones, S.C.2275 Deming Way, Ste. 310Hillhouse InternationalMiddleton, WI 53562

Goods and services

ClassDescriptionStatusFirst use
001Unprocessed plastics; plastics as raw materials being unprocessed plastics; unprocessed plastics in the form of powders, pastes, and granules, all for use in industry, namely, the medical industryACTIVE—
017Plastics in the nature of rods, blocks, tubes, films, pellets and sheets for use in manufacture; plastics in semi-finished form being semi-processed plastics for use in manufacture; plastics in the form of rods being plastic rods; synthetic plastic as semi-finished products in the form of blocks, tubes, and foil all for use in manufacturing in the medical industryACTIVE—
040Custom manufacture of medical devices for others; parts molding, namely, moulding of medical implants for the human bodyACTIVE—
042product research and development, namely, Research and development of products in the field of plastic materials for medical use; scientific information services relating to plastic materials for medical use; industrial medical research information services relating to plastic materials for medical use; provision of technical information in the field of development, research, testing, and evaluation of plastic materials for medical use; technical advice in the field of development, research, testing, and evaluation of plastic materials for medical use; technical solutions provider being the design and implementation of technology solutions for the purpose of product development, research, testing, and evaluation in the field of plastic materials for medical use; engineering design services in the field of the manufacture of medical implants made of plastic materials; design and development of medical products, namely, medical implantable devicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 14, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 19, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 1, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 1, 2025FIMPFINAL DISPOSITION PROCESSED—
Aug 1, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 14, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 14, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 19, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 18, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 18, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 31, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 31, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 25, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 4, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 4, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Dec 4, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 4, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 4, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 25, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 25, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 25, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 23, 2024RFNTREFUSAL PROCESSED BY IB—
Jun 6, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 6, 2024RFRRREFUSAL PROCESSED BY MPU—
May 7, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 6, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 6, 2024DOCKASSIGNED TO EXAMINER—
Feb 27, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 21, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 15, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance